Scientists Tell Congress Coronavirus Lessons Must Be Remembered for Future Epidemics
WASHINGTON — Scientists updated a congressional committee Friday on how the U.S. Energy Department is helping to develop a cure and vaccine for COVID-19.
They said Energy Department supercomputers are unlocking mysteries about the structure of the virus as they look for ways to deactivate it.
The House Science, Space and Technology subcommittee on energy held the hearing as the U.S. death toll from the COVID-19 pandemic approaches 200,000.
“It’s likely that this is not the only pandemic that we’ll see,” said Mary Maxon, a Lawrence Berkeley National Laboratory bioscientist.
She and other witnesses told lawmakers that investments they make now to fight the coronavirus pandemic are likely to benefit the nation far into the future as other diseases threaten the population.
Coronavirus is creating unique challenges for medical researchers because of its unusual characteristics, Maxon said.
“It goes through a process of producing a replication center” inside bodies of infected persons, she said. The virus will not die until the replication center stops duplicating disease cells.
“There are cells that can fuse together to have two nuclei in the cell,” Maxon said. “They’re not sure what it means yet.”
Glenn Randall, a University of Chicago microbiologist, warned against a pattern he’s seen of lawmakers seeking cures to diseases only during an outbreak but then forgetting about the health dangers when the emergency subsides.
A better option is “a multi-pronged attack” to address many disease threats, he said.
He mentioned the example of the Severe Acute Respiratory Syndrome (SARS) outbreak that erupted in China in 2002. It spread worldwide within months but was contained with medicines, mostly antipyretics.
Although COVID-19 is a virus strain similar to SARS, it is unresponsive to the same medicines.
Nevertheless, lessons learned from previous research on SARS is speeding the development of medicines and vaccines for coronavirus, Randall said. He recommended continuing research that could be used to combat future epidemics.
“This is going to go way beyond COVID to any disease,” Randall said.
The scientists won support in their plea for ongoing research from Rep. Lizzie Fletcher, D-Texas, who chairs the energy subcommittee.
“As the COVID-19 pandemic began to unfold in the U.S., it became apparent that [the Energy Department’s] laboratories and programs were also well positioned to help us respond to the virus,” Fletcher said.
She mentioned other biotechnology developed by the Energy Department laboratories as an example for what she would like to see coming from the COVID-19 research.
“Leveraging these capabilities has enabled researchers to develop countermeasures against the novel coronavirus like diagnostic tests and allowed them to assess transmission and evolution dynamics as the virus spreads globally,” Fletcher said in a statement.
In a rare show of bipartisan agreement, Republicans on the subcommittee, such as Rep. Jim Baird of Indiana, largely agreed that the U.S. government needs greater precautions against epidemics.
“I think this basic research is really critical,” Baird said.
The most recent development in the ongoing research is a discovery that coronavirus can damage heart muscle tissue. Researchers at the Rensselaer Polytechnic Institute in Troy, N.Y., published a study that recommends heart medicines to neutralize the disease.
In The News
CAPE TOWN, South Africa (AP) — U.S. plans to donate 500 million more COVID-19 vaccines to developing countries were met Thursday with both celebration and hesitation amid questions over whether the effort will be enough to help poor regions desperate for doses. Some health officials and... Read More
The FDA has authorized the first aid for diagnosing Autism Spectrum Disorder in children 18 months through 5 years of age called Canvas Dx. It was developed by Cognoa, a behavioral health company. “Currently, pediatricians refer most children with suspected developmental delay to specialists to diagnose... Read More
Why do some people get side effects after COVID-19 vaccines? Temporary side effects including headache, fatigue and fever are signs the immune system is revving up -- a normal response to vaccines. And they're common. "The day after getting these vaccines, I wouldn't plan anything that... Read More
Rep. Tom O’Halleran, D-Ariz., has joined Rep. Jodey Arrington, R- Texas, and a bipartisan group of members in a drive to improve the performance standards for health care providers who participate in Medicare’s Accountable Care Organizations, which are part of the Medicare Shared Savings Program. “For... Read More
The Supreme Court this week decided to leave in place a $2 billion verdict in favor of women who claim they developed ovarian cancer from using Johnson & Johnson talc products. As is their custom, the justices did not comment Tuesday on why they rejected Johnson & Johnson's... Read More
WASHINGTON - The Library of Congress has acquired a digital archive of the real-time impressions of more than 200 frontline health care workers documenting the country in crisis during the coronavirus pandemic. The audio diaries from health care workers were collected by The Nocturnists, a medical storytelling... Read More